Perbedaan Organon Pharma Indonesia Tbk. dan Hotel Sahid Jaya International Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Hotel Sahid Jaya International Tbk. diperdagangkan di Rp820 (kapitalisasi pasar 867,48 M, volume 24 jam 1,19 jt). Perbedaan utamanya: Hotel Sahid Jaya International Tbk. jauh lebih besar — sekitar 8,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SHID | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 867,48 M |
Volume | — | 1,19 jt |
Lot | — | 11,87 rb |
Perputaran | — | 1,06 M |
Harga Rata-rata | — | 893,46 |
Nilai Transaksi | — | 1,06 M |
Harga Ekuilibrium Indikatif | — | 820 |
Volume Ekuilibrium Indikatif | — | 38 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Hotel Sahid Jaya International Tbk (the Company) was established on May 23, 1969 based on notary deed No. 36 of Raden Soerojo Wongsowidjojo, S.H., which has been amended through deed No. 26 dated April 14, 1970 of the same notary.
Selengkapnya di halaman SHID →